Julia Margetts serves as the Executive Director of Financial Planning and Analysis (FP&A) in the US at Amicus Therapeutics, having previously held the positions of Senior Director and Director in the same department. Prior experience includes serving as Director of Central Medical Affairs Finance at Bristol Myers Squibb and Associate Director of R&D Portfolio Finance at Celgene, where significant contributions involved forecasting and managing hematology budgets as well as conducting complex financial analyses. Additional roles at Celgene encompassed internal audit consulting, corporate accounting, and accounts receivable analysis, further solidifying expertise in financial operations. Julia holds an MBA in International Business from the University of Scranton and a BS in Accounting from Rutgers University.